Mars Petcare

Mars Petcare is the pet-care division of Mars, Incorporated, a privately held global company. It combines branded pet nutrition with veterinary, diagnostics, science, and technology businesses. Its consumer portfolio includes widely distributed dog and cat food brands such as PEDIGREE, WHISKAS, ROYAL CANIN, IAMS, CESAR, SHEBA, and CRAVE, although brand availability varies by market. The division also operates or owns veterinary and pet-health businesses including BANFIELD Pet Hospital, VCA Animal Hospitals, BluePearl Specialty and Emergency Pet Hospital, and AniCura, as well as diagnostic and data-oriented activities associated with Mars Petcare's broader health strategy. Mars Petcare serves both household consumers and professional customers. Its nutrition business covers everyday feeding, treats, wet and dry food, and specialized diets. ROYAL CANIN is positioned around breed-, size-, age-, and condition-specific nutrition, while other brands are generally marketed through value, mainstream, premium, indulgence, or functional propositions depending on the country. The veterinary network adds clinical care, specialty and emergency medicine, and hospital services. Diagnostics and research capabilities extend the division beyond packaged food into preventive care, clinical decision support, and the study of animal health. The division has expanded through a combination of internally developed brands, international distribution, acquisitions, and investment in the veterinary sector. Mars's purchase of VCA in 2017 significantly increased its presence in North American veterinary hospitals and diagnostics. The company later added or expanded other veterinary platforms, including AniCura in Europe and additional specialty-care capabilities. These moves reflect a strategy of participating in several parts of the pet-care value chain rather than relying only on retail food sales. Mars Petcare also presents pet health, responsible ownership, sustainability, and the human-animal bond as important parts of its public positioning. Through the WALTHAM Petcare Science Institute and related research initiatives, Mars supports research on companion-animal nutrition and wellbeing. Its public programs have included efforts concerning adoption, access to veterinary care, pet population management, and making cities more welcoming to pets. Because Mars is privately held and reports consolidated results rather than a complete public-company segment disclosure for Mars Petcare, detailed division-level financial figures are not consistently available. The business is active internationally, but its exact brand portfolio, services, and corporate structure differ between jurisdictions.

Mars Petcare developed within Mars, Incorporated as the company expanded from confectionery into companion-animal nutrition and services. The division's history is closely connected to the development and international growth of Mars-owned pet-food brands, including PEDIGREE, WHISKAS, IAMS, CESAR, SHEBA, and ROYAL CANIN. Some of these brands entered the Mars portfolio through acquisitions or corporate transactions rather than being created as a single unified product line. As a result, Mars Petcare is best understood as a corporate division and portfolio platform rather than one standalone consumer product brand. The business initially centered on packaged dog and cat food, treats, and related nutrition. Over time, Mars broadened its geographic reach and established different brand positions for different consumer segments. Everyday feeding brands supplied large retail channels, while ROYAL CANIN emphasized specialized nutrition linked to animal size, breed, life stage, and health needs. This portfolio approach enabled Mars to operate across value, mainstream, premium, and veterinary-oriented categories, with local variation in product names and availability. A major strategic change came from the division's move into professional veterinary care and diagnostics. Mars's acquisition of VCA in 2017 brought a substantial network of North American animal hospitals and diagnostic operations into the company. The purchase extended Mars Petcare beyond consumer packaged goods and created a direct connection between nutrition, clinical care, and animal-health information. In 2018, Mars acquired AniCura, adding a major European veterinary network. Mars has also operated or expanded other veterinary platforms, including BANFIELD Pet Hospital and BluePearl Specialty and Emergency Pet Hospital. Mars Petcare's later identity has increasingly included science, preventive health, data, and technology. The WALTHAM Petcare Science Institute has supported research related to companion-animal nutrition, health, and wellbeing. The division has also pursued digital and data-enabled approaches to veterinary medicine and pet ownership. These activities support a broader view of pet care in which food is connected with prevention, diagnosis, treatment, and quality of life. Public initiatives associated with Mars Petcare have addressed responsible pet ownership, adoption, veterinary access, and the role of pets in communities. The company has promoted the human-animal bond and programs intended to improve the conditions in which pets and people live together. Sustainability has also become part of the division's stated agenda, particularly in relation to agricultural inputs, packaging, emissions, and supply-chain practices, although detailed performance differs by program and reporting period. Mars Petcare remains part of privately owned Mars, Incorporated. It operates internationally through a mixture of owned brands, local subsidiaries, veterinary networks, research organizations, and commercial partners. There is no single public listing or consistently reported standalone financial statement for the division. Its current scope is therefore most accurately described as a global pet-care platform spanning nutrition, treats, veterinary services, diagnostics, research, and technology.

• 2018

  Mars acquired AniCura

  [3]Mars completes acquisition of AniCuramars.com

  AniCura became part of Mars, strengthening the company's European veterinary-care network.

• 2017

  Mars acquired VCA

  [2]Mars completes acquisition of VCAmars.com

  The acquisition of VCA expanded Mars Petcare into North American veterinary hospitals and animal-health diagnostics.

A broad, science-oriented pet-care platform combining mass-market and premium nutrition brands with veterinary care, diagnostics, research, and pet-health technology.

• Dog food and treats

  PEDIGREE

  A widely distributed dog-food and treat brand in the Mars portfolio. Its range generally includes complete foods and snacks for different life stages and feeding occasions. Formulations, packaging, and market positioning vary by country.

• Cat food and treats

  WHISKAS

  A global cat-food brand offering wet and dry products for household cats. The portfolio is adapted to local feeding habits and regulatory requirements and commonly includes products organized by age, format, or nutritional need.

• Premium and veterinary pet nutrition

  ROYAL CANIN

  A specialized nutrition brand serving cats and dogs through breed-, size-, life-stage-, and health-oriented formulas. It is sold through retail and veterinary channels and is a central part of Mars Petcare's science-led nutrition positioning.

• Dog and cat food

  IAMS

  A dog- and cat-food brand within Mars Petcare's nutrition portfolio. It generally competes in mainstream and premium retail segments with dry and wet foods designed for different animal sizes, ages, and nutritional requirements.

• Dog food

  CESAR

  A dog-food brand particularly associated with portioned wet meals and small-dog feeding occasions. Product availability and exact recipes differ among markets.

• Cat food

  SHEBA

  A cat-food brand offering wet and dry formats, with an emphasis in many markets on palatability and premium-feeling feeding experiences. Its range is localized across countries.

• Veterinary services

  BANFIELD Pet Hospital

  A veterinary-care network associated with Mars Petcare and focused primarily on companion-animal primary care. Services can include preventive examinations, vaccinations, diagnostics, and treatment, subject to local operations.

• Veterinary services and diagnostics · 2017

  VCA Animal Hospitals

  A North American animal-health platform comprising veterinary hospitals and diagnostic capabilities. It joined Mars through the 2017 acquisition of VCA Inc.

• European veterinary services · 2018

  AniCura

  A European network of animal hospitals and clinics providing companion-animal veterinary care, including referral and specialist services in parts of its network. Mars acquired AniCura in 2018.

• 2021

  Mars Petcare recalls dog food products over vitamin D concerns

  In January 2021, Mars Petcare recalled a range of dog food products. The recall was prompted by concerns that the products contained too much vitamin D to be safe for dogs. The company announced the recall as an urgent measure affecting multiple dog food products within its range. The stated basis for the recall was the elevated vitamin D content and the associated safety concern for dogs consuming the products.

  Source

Read more

• 2018

  Expansion of European veterinary services through AniCuraM&A

  Background

  Mars continued to build a multi-market veterinary platform after entering the North American hospital sector.

  Action taken

  Mars acquired AniCura and added its European animal-hospital and clinic network to Mars Petcare.

  Aftermath

  The acquisition strengthened Mars Petcare's European veterinary footprint and broadened its international pet-health operations.

  Source

• 2017

  Expansion into North American veterinary care through VCAM&A

  Background

  Mars Petcare had a large nutrition business but sought a broader role in pet health and professional services.

  Action taken

  Mars completed its acquisition of VCA, bringing veterinary hospitals and diagnostics into its pet-care portfolio.

  Aftermath

  The transaction materially expanded Mars Petcare's presence in clinical care and animal-health diagnostics.

  Source

• 2018

  Mars completed the acquisition of AniCura[3]Mars completes acquisition of AniCuramars.com

  M&A

  Mars acquired AniCura, strengthening its presence in European veterinary care through a network of animal hospitals and clinics.

• 2017

  Mars completed the acquisition of VCA[2]Mars completes acquisition of VCAmars.com

  M&A

  Mars acquired VCA Inc., expanding Mars Petcare into a large North American network of veterinary hospitals and animal-health diagnostics.

1. 1Mars Petcaremars.com
2. 2Mars completes acquisition of VCAmars.com
3. 3Mars completes acquisition of AniCuramars.com
4. 4Mars Petcare recalls dog food products over vitamin D concernsgazette-news.co.uk